Efpeglenatide SAR439977

DRUG2 trials

Sponsors

Sanofi

Conditions

Type 2 Diabetes Mellitus

Phase 3

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)

TerminatedNCT03713684

SanofiType 2 Diabetes Mellitus

Start: 2018-11-09End: 2021-01-04Updated: 2021-12-02

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea

TerminatedNCT03770728

SanofiType 2 Diabetes Mellitus

Start: 2019-08-01End: 2020-12-27Updated: 2021-12-02